¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cardiac risk"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • risk benefit ratio
    À§ÇèÆíÀͺñ
  • risk difference
    À§ÇèµµÂ÷ÀÌ
  • risk factor
    À§ÇèÀÎÀÚ
  • risk management
    À§Çèµµ°ü¸®
  • risk marker
    À§ÇèÇ¥ÁöÀÚ
  • risk ratio
    À§Çèºñ
  • advanced cardiac life support
    »ó±Þ½ÉÀå¼Ò»ý¼ú, Àü¹®½ÉÀå¼Ò»ý¼ú
  • absolute cardiac dullness
    Àý´ë½ÉÀåµÐŹÀ½
  • cardiac
    1. ½ÉÀå- 2. µé¹®-, ºÐ¹®- 3. ½ÉÀ庴ȯÀÚ
  • cardiac arrest
    ½ÉÀåÁ¤Áö
  • cardiac arrhythmia
    ½ÉÀåºÎÁ¤¸Æ
  • cardiac asthma
    ½ÉÀåõ½Ä
  • cardiac beriberi
    ½ÉÀå°¢±â
  • cardiac catheterization
    ½ÉÀåµµ°ü»ðÀÔ, ½ÉÀåÄ«Å×ÅÍ»ðÀÔ
  • cardiac chamber
    ½É½Ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cardiac rate
    (¢¡heart rate) ½ÉÀå¹Úµ¿¼ö
  • cardiac temponade
    ½ÉÀå´­¸²Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lifetime risk
    Æò»ýÀ§Çèµµ
  • multiple risk
    ´ÙÁßÀ§Çèµµ
  • risk management
    À§Çèµµ°ü¸®
  • risk marker
    À§Ç赵ǥÁö
  • time dependent relative risk model
    ½Ã°£ÀÇÁ¸»ó´ëÀ§Çè¸ðµ¨
  • operative risk
    ¼ö¼úÀ§Çèµµ
  • physical hazard risk
    ¹°¸®ÀûÀ¯ÇØÀ§Çèµµ
  • population attributable risk
    ÀϹÝÀα¸±â¿©À§Çèµµ
  • risk
    À§Çè, À§Çèµµ
  • radiation risk
    ¹æ»ç¼±À§Çèµµ
  • recurrence risk
    Àç¹ßÀ§Çèµµ
  • relative risk
    ºñ±³À§Çèµµ
  • risk ratio
    À§Çèµµºñ
  • risk benefit ratio
    À§ÇèÆíÀͺñ
  • surgical risk
    ¼ö¼úÀ§Çèµµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Cine-CT cardiac imaging
    ½ÉÀå Àü»êÈ­ ´ÜÃþ ¿µÈ­»ó
  • Functional cardiac murmur
    ±â´É¼º½ÉÀâÀ½(¡­ãýíÚëå)
  • Gravity, cardiac output and
    Áß·Â(ñìÕô), ½É¹ÚÃâ·®(ãýÚÑõóÕá)
  • Insufficiency, cardiac valve
    ½ÉÀåÆÇ¸·ºÎÀüÁõ(ãýíô÷ûدÜôîïñø)
  • absolute cardiac dullness
    Àý´ë½ÉµÐŹÀ½(ï¾ÓßãýöúëåÍ£).
  • advanced cardiac life support
    ÀÌÂ÷ (½ÉÆó)¼Ò»ý¼ú
  • great cardiac vein
    Å«½ÉÀåÁ¤¸Æ
  • heart loop =cardiac l.
    ½ÉÀå·ç¿ìÇÁ.
  • heart stoppage =cardiac arrest
    ½É(¹Ú)Á¤Áö(ãýÚÑïÎò­).
  • heart stoppage =cardiac arrest
    ½É(¹Ú)Á¤Áö(ãýÚÑïÎò­).
  • hypertrophy, cardiac
    ½ÉÀåºñÈÄ.
  • impure cardiac sound
    ºÒ¼ø½ÉÀ½.
  • inferior cervical cardiac branches
    ¾Æ·¡¸ñ½ÉÀå°¡Áö
  • inferior cervical cardiac nerve
    ¾Æ·¡¸ñ½ÉÀå½Å°æ
  • primitive cardiac bulb
    ¿ø½Ã½ÉÀ寨´ë
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • radiation risk
    ¹æ»ç¼±À§ÇØ, ¹æ»ç¼± À§Çè
  • radiation risk coeffecient
    ¹æ»ç¼±À§ÇèÁö¼ö
  • recurrence risk
    Àç¹ßÀ§Çè
  • relative risk
    ºñ±³À§Çèµµ
  • relative risk
    ºñ±³À§Çèµµ(ËÓË´Ëô̴̬).
  • relative risk estimation
    »ó´ë(-Àû) À§Çèµµ ÃßÁ¤(õÏïÒ)
  • risk factor
    À§ÇèÀÎÀÚ
  • risk factors
  • risk management
    À§Çè°ü¸®.
  • risk-benefit analysis
    À§Çè-À̵æºÐ¼®
  • surgical risk
    ¼ö¼úÀ§Çèµµ(¼ö¼úÀ§ÇèŹ).
  • time dependent relative risk model
    ½Ã°£ÀÇÁ¸¼º »ó´ëÀ§Çè¸ðµ¨
  • absolute cardiac dullness
    Àý´ë½ÉµÐŹÀ½(ï¾ÓßãýöúëåÍ£).
  • advanced cardiac life support
    ÀÌÂ÷ (½ÉÆó)¼Ò»ý¼ú
  • axis of heart ; cardiac axis
    ½ÉÀåÃà(¡­õî).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Cardiac prominence
    ½ÉÀåÀ¶±â
    [¿¾ ¿ë¾î] ½ÉÀåÀ¶±â
  • Cardiac impression
    ½ÉÀåÀÚ±¹
    [¿¾ ¿ë¾î] ½É¾ÐÈç
  • Cardiac conducting system
    ½ÉÀåÀüµµ°èÅë
    [¿¾ ¿ë¾î] ½ÉÀåÀÚ±ØÀüµµ°è
  • Cardiac veins
    ½ÉÀåÁ¤¸Æ
    [¿¾ ¿ë¾î] ½ÉÀåÁ¤¸Æ
  • Inferior cervical cardiac branches
    ¾Æ·¡¸ñ½ÉÀå°¡Áö
    [¿¾ ¿ë¾î] Çϰæ½ÉÀåÁö
  • Inferior cervical cardiac nerve
    ¾Æ·¡¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] Çϰæ½ÉÀå½Å°æ
  • Primitive cardiac bulb
    ¿ø½Ã½ÉÀ寨´ë
    [¿¾ ¿ë¾î] ¿ø½Ã½É±¸
  • Cardiac gland
    À§µé¹®»ù
    [¿¾ ¿ë¾î] ºÐ¹®¼±
  • Secretory cell of cardiac gland
    À§µé¹®»ù¼¼Æ÷
    [¿¾ ¿ë¾î] ºÐ¹®¼±¼¼Æ÷
  • Superior cervical cardiac branches
    À§¸ñ½ÉÀå°¡Áö
    [¿¾ ¿ë¾î] »ó°æ½ÉÀåÁö
  • Superior cervical cardiac nerve
    À§¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] »ó°æ½ÉÀå½Å°æ
  • Small cardiac vein
    ÀÛÀº½ÉÀåÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼Ò½ÉÀåÁ¤¸Æ
  • Middle cervical cardiac nerve
    Áß°£¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] Áß°æ½ÉÀå½Å°æ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cine cardiac magnetic resonance imaging
    ¿µÈ­½ÉÀåÀÚ±â°ø¸í¿µ»ó
  • multiphase cardiac imaging
    ´ÙÁßÀ§»ó ½ÉÀ念»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
MCRI Multifactorial Cardiac Risk Index
ACD absolute cardiac dullness; absolute claudication distance; acid-citrate-dextrose [solution]; actinom...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AR Attributable Risk
BRFSS Behavioral Risk Factor Surveillance System
CVRF Cardiovascular risk factor
CRIB Clinical Risk Index for Babies
CARDIA Coronary Artery Risk Development In Young Adults
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cardiac allograft
    ½ÉÀå µ¿Á¾ À̽Ä
    ½ÉÀåÀÇ µ¿ÀÏÁ¾À̱â´Â Çϳª À¯ÀüÀÚÇüÀ» ´Þ¸®ÇÏ´Â °³Ã¼°£ ÀÇ Á¶Á÷ÀÌ½ÄÆí.
  • cardiac anomaly
    ½É ÀÌ»ó, ½ÉÀå ÀÌ»ó, ½ÉÀå ±âÇü
    ½ÉÀåÀÌ ¼±ÃµÀû, À¯ÀüÀûÀÎ °áÇÔÀÇ °á°ú·Î¼­ Á¤»ó±âÁØ¿¡¼­ ¸¹ÀÌ ¶³¾îÁø °Í.
  • cardiac arrest
    ½É Á¤Áö, ½ÉÀå Á¤Áö
    ½ÉÀåÀÇ ±â´ÉÀÌ ¸ØÃß´Â °Í. ½ÉÀåÀÇ ±â´ÉÀÌ ¿ÏÀüÈ÷ Á¤ÁöµÇ´Â °Í.
  • cardiac assist
    ½É º¸Á¶
    ½ÉÀåÀ» º¸Á¶ÇÏ´Â °Í.
  • cardiac asthma
    ½ÉÀμº õ½Ä
    ÁÂ½É½Ç ºÎÀü°ú °°Àº ½ÉÀå Áúȯ¿¡ ¼ö¹ÝÇÏ¿© ÀϾ´Â ¹ßÀÛ¼º È£Èí °ï¶õ.
  • cardiac branch
    ½ÉÀå °¡Áö, ½ÉÀåÁö
    ½ÉÀå¿¡¼­ ºÐÇÒ ¶Ç´Â ÆÄ»ýÇÑ °Í.
  • cardiac catheter
    ½ÉÀå Ä«Å×ÅÍ
    X¼± Åõ½ÃÇÏ¿¡ ¸»ÃÊÇ÷°üÀ» ÅëÇÏ¿© ½É¹æ, ½É½Ç¿¡ »ðÀÔÇϵµ·Ï ¸¸µç Ư¼ö Ä«Å×ÅÍ.
  • cardiac chamber
    ½É½Ç
    µ¿ÀǾî=cardiac ventricle.
  • cardiac compensation
    ½ÉÀå ´ë»ó
    ½ÉÀå°ú °ü·ÃµÈ Áõ»óÀ» ³ªÅ¸³»Áö ¾Ê°Ô ½ÉÀåÀÌ ÀûÀýÇÑ Ç÷·ù·®À» À¯ÁöÇϰí ÀÖ´Â °Í.
  • cardiac contraction
    ½ÉÀå ¼öÃà
    ½ÉÀå±ÙÀ°ÀÇ ¼öÃà°ú °ü·ÃÇÏ¿© ´ÜÃà°ú ±äÀåÀÇ ¹ß»ýÀ» ¶æÇÑ´Ù.
  • cardiac cycle
    ½ÉÀå ÁÖ±â, ½É ÁÖ±â
    ½É¹æ°ú ½É½ÇÀº ½Ã°£ÀûÀ¸·Î µ¿½Ã´Â ¾Æ´ÏÁö¸¸ ¼öÃà°ú È®ÀåÀ» °ÅµìÇϰí ÀÖ°í, ÀÌ ÁÖ±âÀûÀΠȰµ¿ÀÌ ½É¹Úµ¿ÀÌ°í ½É¹Úµ¿ÀÇ Áֱ⸦ ½ÉÁÖ±â¶ó°í ÇÑ´Ù.
  • cardiac decompensation
    ½É´ë»ó ºÎÀü, ½É½ÇÁ¶, ½ÉÀå ½ÇÁ¶, ½É ±â´É ´ë»ó ºÎÀü
    ½ÉÀåÀÌ ´ë»ó¼º ±â´É Áï ºñ´ë³ª ºó¸Æ µîÀ¸·Î ÃæºÐÈ÷ ¼øÈ¯ Ç÷·ù·®À» À¯ÁöÇÏÁö ¸øÇÏ´Â »óÅÂ.
  • cardiac depressant
    ½É ¾ïÁ¦Á¦
    ½É¹Ú ¼öÀÇ °¨¼Ò¿Í ½ÉÀå ¼öÃà·ÂÀÇ ÀúÇϸ¦ ÀÏÀ¸Å°´Â ¾à¹°.
  • cardiac disorder
    ½ÉÀå Áúȯ
    ½ÉÀåÀÇ Àå¾Ö, ºÎÁ¶È­, Áúȯ. ±â´ÉÀÇ È¥¶õ ¶Ç´Â ºñÁ¤»ó.
  • cardiac dysfunction
    ½É ±â´É Àå¾Ö, ½ÉÀå ±â´É Àå¾Ö
    ½ÉÀåÀÇ ±â´ÉÀå¾Ö ¶Ç´Â ÀÌ»ó.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
risk-taking Undertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. It may also include the exhibiting of certain behaviours whose outcomes may present a risk to the individual or to those associated with him or her.
(12 Dec 1998)
competing risk An event that removes a subject from being at risk for an outcome under investigation.
(05 Mar 2000)
pregnancy, high-risk Pregnancy in which the mother and/or foetus are at greater than normal risk of morbidity or mortality. Causes include lack of adequate prenatal care, previous obstetrical history, pre-existing maternal disease or pregnancy-induced disease, and multiple gestation, as well as advanced maternal age.
(12 Dec 1998)
health risk assessment Method of describing an individual's chance of falling ill or dying of a specified condition, based on actuarial calculations that allow for known exposure to risk; expressed as expected age at which death or disease will occur, and intended as a way of drawing an individual's attention to the probable consequences of risk behaviour.
(05 Mar 2000)
oesophageal carcinoma risk factors <radiology> P Plummer-Vinson Web, A achalasia, alcohol, B Barrett oesophagus, S stricture, T tylosis, tobacco see: oesophageal carcinoma
(12 Dec 1998)
thyroid carcinoma risk factors <radiology> Increased risk of malignancy: young female, male, history of radiation to head or neck, hard lesion, other neck masses, no shrinkage on TSH, family hx of thyroid carcinoma see: thyroid carcinoma
(12 Dec 1998)
empiric risk The chance that a disease will occur in a family based upon experience (past history, medical records, etc.) rather than theory.
(12 Dec 1998)
abnormal cleavage of cardiac valve Congenital malformation of a valve leaflet with a defect extending from the free margin.
(05 Mar 2000)
anterior cardiac veins Two or three small veins in the anterior wall of the right ventricle opening directly into the right atrium independently of the coronary sinus.
Synonym: venae cordis anteriores.
(05 Mar 2000)
area of cardiac dullness A triangular area determined by percussion of the front of the chest; it corresponds to the part of the heart that is not covered by lung tissue.
(05 Mar 2000)
cardiac <cardiology> Pertaining to the heart.
Origin: L. Cardiacus from Gr. Kardiakos
(16 Dec 1997)
cardiac accident Sudden cardiac catastrophe, such as may result from coronary occlusion.
(05 Mar 2000)
cardiac albuminuria Albuminuria caused by congestive heart failure.
(05 Mar 2000)
cardiac alternation The occurrence of any cardiac phenomenon every other beat.
(05 Mar 2000)
cardiac aneurysm Thinning, stretching, and bulging of a weakened ventricular wall, usually as a result of myocardial infarction; rarely postinflammatory or congenital.
Synonym: mural aneurysm, ventricular aneurysm.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • security risk
    (Ä¡¾È»óÀÇ)À§Çè Àι°
  • war risk insurance
    ÀüÀï º¸Çè
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á